Trials / Completed
CompletedNCT03979807
A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)
The Role of Inhaler Device in the Treatment Persistence With Dual Bronchodilators in Patients With COPD
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 11,296 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 1 Year – 40 Years
- Healthy volunteers
- Not accepted
Summary
To compare the persistence in using two different medications from the same drug class (LAMA/LABA FDC) which are delivered through different devices, a dry-powder inhalers (DPI) and Soft Mist Inhalers (SMI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olodaterol/Tiotropium Bromide | (Stiolto®) delivered via Respimat inhaler |
| DRUG | Umeclidinium/ Vilanterol | (Anoro®) delivered via Ellipta Inhaler |
Timeline
- Start date
- 2019-06-10
- Primary completion
- 2019-06-11
- Completion
- 2019-06-11
- First posted
- 2019-06-07
- Last updated
- 2021-11-15
- Results posted
- 2020-07-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03979807. Inclusion in this directory is not an endorsement.